These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36597887)

  • 1. Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Pi H; Xia L; Ralph DD; Rayner SG; Shojaie A; Leary PJ; Gharib SA
    Circ Res; 2023 Feb; 132(3):254-266. PubMed ID: 36597887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
    Simpson CE; Coursen J; Hsu S; Gough EK; Harlan R; Roux A; Aja S; Graham D; Kauffman M; Suresh K; Tedford RJ; Kolb TM; Mathai SC; Hassoun PM; Damico RL
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L836-L848. PubMed ID: 37070742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension.
    Chang WT; Shih JY; Hong CS; Lin YW; Chen YC; Ho CH; Chen ZC; Roan JN; Hsu CH
    ESC Heart Fail; 2021 Aug; 8(4):3082-3092. PubMed ID: 33955184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted proteomics of right heart adaptation to pulmonary arterial hypertension.
    Amsallem M; Sweatt AJ; Arthur Ataam J; Guihaire J; Lecerf F; Lambert M; Ghigna MR; Ali MK; Mao Y; Fadel E; Rabinovitch M; de Jesus Perez V; Spiekerkoetter E; Mercier O; Haddad F; Zamanian RT
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33334941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children.
    Said F; Haarman MG; Roofthooft MTR; Hillege HL; Ploegstra MJ; Berger RMF
    J Pediatr; 2020 May; 220():139-145. PubMed ID: 32113658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
    Simpson CE; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies MK; Vaidya RD; Brandal S; Pauciulo MW; Austin ED; Ivy DD; Nichols WC; Everett AD
    Chest; 2020 Jun; 157(6):1606-1616. PubMed ID: 31987881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
    Rich JD; Thenappan T; Freed B; Patel AR; Thisted RA; Childers R; Archer SL
    Int J Cardiol; 2013 Aug; 167(3):669-76. PubMed ID: 22459397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
    Haddad F; Contrepois K; Amsallem M; Denault AY; Bernardo RJ; Jha A; Taylor S; Arthur Ataam J; Mercier O; Kuznetsova T; Vonk Noordegraaf A; Zamanian RT; Sweatt AJ
    Chest; 2022 May; 161(5):1347-1359. PubMed ID: 34774527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
    Rhodes CJ; Wharton J; Swietlik EM; Harbaum L; Girerd B; Coghlan JG; Lordan J; Church C; Pepke-Zaba J; Toshner M; Wort SJ; Kiely DG; Condliffe R; Lawrie A; Gräf S; Montani D; Boucly A; Sitbon O; Humbert M; Howard LS; Morrell NW; Wilkins MR
    Am J Respir Crit Care Med; 2022 May; 205(9):1102-1111. PubMed ID: 35081018
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of right ventricular adaptability to loading conditions can improve the timing of listing to transplantation in patients with pulmonary arterial hypertension.
    Dandel M; Knosalla C; Kemper D; Stein J; Hetzer R
    J Heart Lung Transplant; 2015 Mar; 34(3):319-28. PubMed ID: 25662858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of right ventricle in pulmonary arterial hypertension with three-dimensional echocardiography and cardiovascular magnetic resonance.
    Lattanzio M; Scelsi L; Golino M; Lattuada M; Raineri C; Turco A; Giuntini C; Ceriani F; Curti M; Bonelli A; Piacentino F; Venturini M; Ghiringhelli S; Morandi F; De Ponti R; Ghio S
    J Cardiovasc Med (Hagerstown); 2021 Dec; 22(12):929-936. PubMed ID: 34482325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Lichodziejewska B; Kurnicka K; Szewczyk A; Glińska-Wielochowska M; Kurzyna M; Błaszczyk M; Liszewska-Pfejfer D; Pruszczyk P
    Clin Rheumatol; 2008 Aug; 27(8):991-7. PubMed ID: 18256871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.